METASTATIC breast cancerCANCER relapseCANCER patientsDUCTAL carcinomaBREAST cancerCAUSES of deathObjective: Unusual clinical course. Background: Breast cancer (BC) is the most common malignant disease in females and one of the leading causes of death worldwide. Its treatment plan includes a lon...
651 - Treatment of recurrent cutaneous metastatic breast cancer with tin ethyl etiopurpurln (SnET2) photodynamic therapy Breast cancer is the most commonly diagnosed cancer in women and the second leading cause of cancer deaths among women in the United States. Many women dia... S T.,Mang,and...
We report a case of a 65-year-old Caucasian woman who presented with cutaneous lupus erythematosus after receiving paclitaxel-bevacizumab combination treatment as first-line therapy for metastatic breast cancer. Her cutaneous symptoms and increased serum anti-SSA and anti-SSB antibodies disappeared shortl...
Cutaneous metastasis (CM) accounts for 5–30% of patients with breast cancer (BC) and presents unfavorable response to treatment and poor prognosis. A better understanding of the molecular alterations involved in metastasis is essential, which would help identify diagnostic and efficacy biomarkers for...
Exomic sequencing is routinely performed on metastatic melanoma samples to identify key mutations that have an impact on treatment and prognosis. The Cancer Genome Atlas Network has recently proposed a classification schema for cutaneous melanoma (CM) based on mutations, including BRAF, RAS, NF-1, ...
and for the treatment of breast cancer she had been exposed to drugs such astamoxifenandfulvestrant(ER inhibitors),anastrazoleandletrozole(aromatase inhibitors), all of which have been associated in case reports of vasculitis. On the other hand, a breast cancer patient with metastatic relapse also...
Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node Lymphatic mapping and sentinel node biopsy are well-established techniques for staging and managing patients with melanoma, breast cancer and other maligna... AJ Cochran,DR ...
Ipilimumab is an immune-modifying monoclonal antibody that promotes unrestrained T cell activation against tumor cells, used as an intravenous treatment for metastatic melanoma and with promising results in trials on ovarian cancer, prostate cancer, and metastatic renal cancer. Immu...
Cutaneous metastases of lung cancer are infrequent, and such a rapid growth is unusual.The interval between the appearance of the first cutaneous metastatic... M Baroni,M Cazzaniga 被引量: 0发表: 1979年 [Cutaneous-subcutaneous path of metastasis and its resection in surgery for cancer of the ...
tuberculosis infection (LTBI); to identify individuals more likely to have LTBI and/or higher risk of becoming ill; to indicate the correct treatment; to notify patients who will be treated for LTBI and to monitor the treatment of these patients. One should consider that PPD has limitations, ...